1,086,191 Shares in BiomX Inc. (NYSEAMERICAN:PHGE) Purchased by 8Vc Gp I LLC

8Vc Gp I LLC acquired a new position in BiomX Inc. (NYSEAMERICAN:PHGE) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,086,191 shares of the company’s stock, valued at approximately $304,000. BiomX comprises about 0.3% of 8Vc Gp I LLC’s portfolio, making the stock its 3rd biggest position. 8Vc Gp I LLC owned about 2.36% of BiomX as of its most recent SEC filing.

BiomX Price Performance

Shares of NYSEAMERICAN PHGE remained flat at $0.34 during trading on Friday. The stock had a trading volume of 81,739 shares, compared to its average volume of 217,868. The company has a debt-to-equity ratio of 1.75, a current ratio of 4.40 and a quick ratio of 1.58. BiomX Inc. has a 1 year low of $0.19 and a 1 year high of $0.86. The company has a market capitalization of $23.74 million, a P/E ratio of -0.56 and a beta of 1.31.

BiomX (NYSEAMERICAN:PHGE) last released its quarterly earnings results on Wednesday, April 3rd. The company reported ($0.08) earnings per share for the quarter. Research analysts anticipate that BiomX Inc. will post -0.52 EPS for the current year.

Analyst Ratings Changes

Separately, HC Wainwright restated a “buy” rating and issued a $2.00 target price on shares of BiomX in a research report on Wednesday, April 3rd.

BiomX Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).